THTX (Theratechnologies, Inc.) Sof foyda

THTX (Theratechnologies) - kompaniyaning tovar belgisi

Theratechnologies Inc. (THTX) OIV bilan yashayotgan insonlar uchun terapiyani joriy etish orqali mablag'larning barqaror kirimini ta'minlaydi, bu esa uning pul oqimlarini bozor tebranishlariga chidamli qiladi. Ushbu narxlar grafigi joriy ko'rsatkich -0.01 ekanligini namoyish etadi. Kompaniya o'zining yuqori darajada ixtisoslashgan mahsulotlari bo'yicha sezilarli narx belgilash imkoniyatiga ega, garchi hukumat xaridlari cheklovlari narxlarni yanada oshirish imkoniyatlarini qisman cheklasa-da.

THTX (Theratechnologies Inc.) Sof foyda tarixi 04.07.2022dan 11.10.2025gacha

Theratechnologies (THTX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Theratechnologies, Inc|THTX - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Theratechnologies, Inc|THTX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Theratechnologies|THTX - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi theratech.com|THTX - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Theratechnologies Inc.|THTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Theratechnologies, Inc.|THTX - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Theratechnologies, Inc|THTX - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Theratechnologies|Shoshilinch likvidlik theratech.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
THTX - Sof daromad
Kompaniyaning jamlanma tahlili:Theratechnologies Inc.
Theratechnologies Inc asosiy tovari

Ushbu ko'rsatkich kunlik umumiy moliyaviy natijani to'plab, biznes pul oqimlarining haqiqiy barqarorligini aks ettiradi. U yakuniy sof foydani o'lchaydi va tashqi o'sish dinamikasi ortidagi yashirin qarz risklarini aniqlash imkonini beradi. Theratechnologies Inc. (THTX) kompaniyasining operatsion foydasi OIVga qarshi dori vositalari uchun generik dori vositalarining yo'qligi tufayli yuqori marjalarni namoyon etadi. Ushbu himoyalangan nisha raqobatchilar tomonidan narxlarga bo'lgan bosimni minimallashtirib, aktiv uchun barqaror investitsiya profilini shakllantiradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN: Sof daromad|Pharming Corp - Soliqlar to‘langandan keyingi foyda|NKTR: Sof foyda|upstreambio.com - Yakuniy foyda|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|Sof foyda pieris.com PVLA|SVRA: Sof daromad|Rigel Pharma - Soliqlar to‘langandan keyingi foyda|ANAB: Sof foyda|Kompaniyaning sof daromadi Astria Corp (ATXS)|ENGN (enGene Holdings Inc.) - Sof foyda|Sof daromad rapt.com (RAPT)|Sof foyda JBIO|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Kyverna KYTX|TLSA: Kompaniya foydasi|CABA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi ventyxbio.com|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|ELDN (Eledon Pharmaceuticals Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Agenus Inc|Kompaniyaning sof daromadi Climb Bio, Inc CLYM|Sof foyda ZURA|atyrpharma.com (ATYR) - Yillik sof foyda|Sof foyda ADAG (Adagene Inc.)|Sof moliyaviy natija ImageneBio (IMA)|Shattuck Therapeutics - Sof foyda|Kompaniyaning sof daromadi Equillium, Inc.|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|IMUX - Sof moliyaviy natija|Sof daromad ATRA|IFRX: Yakuniy foyda|Sof foyda XFOR|Sof moliyaviy natija adicetbio.com|Kompaniyaning sof foydasi Celularity CELU|INMB: Kompaniya foydasi|Barinthus Biotherapeutics plc - Sof foyda|Kezar Life Sciences Inc. (KZR) - Sof daromad|SABS (SAB Biotherapeutics, Inc) - Sof daromad|AKTX - Sof moliyaviy natija|Sof daromad ENLV|QTTB (Q32 Bio Corp) - Soliqlar to‘langandan keyingi foyda|Sof foyda GOVX|EDSA (Edesa Biotech Inc) - Yakuniy foyda|iBio Corp - Sof daromad|Soliqlar to‘langandan keyingi foyda CARM (Carisma Therapeutics Inc)|XTLB: Sof daromad|BOLT (Bolt Biotherapeutics) - Kompaniya foydasi|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi